Suppr超能文献

2003年至2012年间安大略省前列腺特异性抗原前列腺癌筛查的接受情况变化。

Changes in the uptake of screening for prostate cancer with prostate-specific antigen in Ontario between 2003 to 2012.

作者信息

Watson Louis

机构信息

email:

出版信息

Can Oncol Nurs J. 2020 Apr 1;30(2):125-132. doi: 10.5737/23688076302125132. eCollection 2020 Spring.

Abstract

OBJECTIVES

This study investigates change in prostate-specific antigen (PSA) screening uptake in Ontario among men 35 years of age and older, between 2003 and 2012. We identify factors related to PSA testing, and examine the degree to which age guidelines for PSA testing are being followed or if PSA screening is opportunistic in nature. The relationship of income, education and having a regular physician and an estimation of PSA testing prevalence in 2012 is also studied.

METHODS

Data from the Canadian Community Health Survey (CCHS) were used to estimate the proportion of men who had a PSA test in 2003 and then compared to a similar estimate (in similar population) in 2012. We also examined associations with PSA uptake to socio-demographic factors. Contingency table analyses were performed to characterize the changes; logistic regression was also used to evaluate the differences, while taking into account the possible confounding role of other factors.

RESULTS

We found among men aged 35-49 years and 75+, there was an increase in PSA utilization between 2003 and 2012. In 2003, 18% of men 35-49 years, and 74% of men aged 75+ reported ever having a PSA test. These figures increased to 20% of men aged 35-49 years, and 84% of men aged 75+ years in 2012. Logistic regression showed that a man in the 70-74 age category in 2012 had the highest likelihood of having had a PSA test compared to men in the age range of 35-49 years (odds ratio (OR)=25.9; confidence interval (CI)= 19.9-33.8).

CONCLUSION

In Ontario, PSA testing is seemingly opportunistic in nature and occurring in groups not recommended for testing by the Ontario guidelines. There is a marked increase in PSA utilization in age ranges outside of the current Ontario PSA testing guidelines (35-49 and 75+). It would appear that most PSA testing in Ontario is opportunistic and adherence to age guidelines is limited.

摘要

目的

本研究调查了2003年至2012年间安大略省35岁及以上男性前列腺特异性抗原(PSA)筛查的接受情况变化。我们确定与PSA检测相关的因素,并检查遵循PSA检测年龄指南的程度,或者PSA筛查是否本质上是机会性的。还研究了收入、教育程度、是否有固定医生与2012年PSA检测患病率估计之间的关系。

方法

使用加拿大社区健康调查(CCHS)的数据来估计2003年进行PSA检测的男性比例,然后与2012年(类似人群中)的类似估计进行比较。我们还研究了PSA接受情况与社会人口因素之间的关联。进行列联表分析以描述变化情况;在考虑其他因素可能的混杂作用时,还使用逻辑回归来评估差异。

结果

我们发现,在35 - 49岁和75岁以上的男性中,2003年至2012年间PSA检测的使用率有所增加。2003年,35 - 49岁男性中有18%,75岁以上男性中有74%报告曾进行过PSA检测。2012年,这些数字分别增至35 - 49岁男性中的20%和75岁以上男性中的84%。逻辑回归显示,与35 - 49岁年龄组的男性相比,2012年70 - 74岁年龄组的男性进行PSA检测的可能性最高(优势比(OR)=25.9;置信区间(CI)=19.9 - 33.8)。

结论

在安大略省,PSA检测似乎本质上是机会性的,并且在安大略省指南不建议检测的人群中进行。在当前安大略省PSA检测指南范围之外的年龄组(35 - 49岁和75岁以上),PSA检测的使用率有显著增加。看来安大略省的大多数PSA检测是机会性的,对年龄指南的遵循有限。

相似文献

10
Opportunistic prostate cancer screening: A population-based analysis.机会性前列腺癌筛查:基于人群的分析。
Urol Oncol. 2020 May;38(5):393-400. doi: 10.1016/j.urolonc.2019.12.009. Epub 2020 Jan 14.

本文引用的文献

1
3
Recent trends in prostate cancer in Canada.加拿大前列腺癌的最新趋势。
Health Rep. 2019 Apr 17;30(4):12-17. doi: 10.25318/82-003-x201900400002-eng.
4
Prostate cancer screening: where are we now?前列腺癌筛查:我们目前处于什么阶段?
BJU Int. 2019 Jun;123(6):916-917. doi: 10.1111/bju.14692. Epub 2019 Feb 19.
7
Implications of false-positive results for future cancer screenings.假阳性结果对未来癌症筛查的影响。
Cancer. 2018 Jun 1;124(11):2390-2398. doi: 10.1002/cncr.31271. Epub 2018 Apr 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验